ULTRA FLUIDE VISAGE
ULTRA FLUIDE VISAGE
Approved
DIN Number
02490021
Drug Class
Human
Market Date
Apr 15, 2020
Company
HC
laboratoires la roche-posay canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02490021
AIG Number0761590001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Product Specifications
Dosage FormLotion
Route of AdministrationTopical
AHFS Classification84:80.00
Health Canada Classification
ACTIVE INGREDIENTS (7)
AVOBENZONEActive
Strength: 3 % / W/W
Monograph: AVOBENZONE
BEMOTRIZINOLActive
Strength: 5 % / W/W
Monograph: BEMOTRIZINOL
DROMETRIZOLE TRISILOXANEActive
Strength: 7 % / W/W
Monograph: DROMETRIZOLE TRISILOXANE
ENSULIZOLEActive
Strength: 0.5 % / W/W
Monograph: ENSULIZOLE
HOMOSALATEActive
Strength: 2 % / W/W
Monograph: HOMOSALATE
OCTISALATEActive
Strength: 5 % / W/W
Monograph: OCTISALATE
OCTOCRYLENEActive
Strength: 5 % / W/W
Monograph: OCTOCRYLENE